Bharat

Big Boost To ‘Aatmanirbhar Bharat Abhiyan’, Budgetary Support For Defence Innovation Approved

US regulator refuses emergency use approval for Covaxin | Audio Bulletin

No Emergency Use Approval For Covaxin In US; Phase 3 Trial Data Expected To Be Published In 7-8 Days, Says Dr VK Paul

Will truth over COVID deaths will ever come to light? | Bharat Ki Baat(10.06.2021)

Covid Vaccine Prices To Be Revised, Centre In Talks With Serum Institute & Bharat Biotech: Sources

Monsoon brings Mumbai to a standstill | Bharat Ki Baat (09.06.2021)

Early Covaxin Study Shows Protections Against Beta & Delta Variants Of Covid-19

People openly flout COVID-19 protocols | Bharat ki baat (8 June 2021)

Know about India mission 'December 31' | Bharat Ki Baat (7 June 2021)

Covishield Elicits Better Antibody Response Than Covaxin: Study

AIIMS Delhi To Begin Covaxin Trials On Children Today Amid Third Wave Scare

Clinical trial of Bharat Biotech's vaccine on children to start from tomorrow in Delhi AIIMS